Skip to main content

Table 2 Effect of multivitamin supplementation on anthropometric measurements

From: A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania

Outcome

Time Point (n) a

Placebo

Multivitamins

Hodges-Lehmann

p-valuec

  

Median (IQR)b

Median (IQR)b

95% CI

 
    

(Multivitamin-Placebo)

 

Weight, kg

     
 

Baseline (255)

7.95 (6.20, 10.75)

8.48 (6.52, 10.81)

(-1.15, 0.36)

0.31

 

Intermediate (245)

8.52 (6.84, 11.43)

9.38 (7.08, 11.81)

(-0.35, 1.28)

0.30

 

Final (237)

9.01 (7.20, 12.02)

9.80 (7.74, 11.94)

(-0.38, 1.31)

0.28

 

Change (237)

0.84 (0.45, 1.30)

0.84 (0.51, 1.30)

(-0.15, 0.18)

0.82

Height, cm

     
 

Baseline (255)

74.00 (67.50, 87.00)

77.50 (68.00, 86.55)

(-4.60, 1.00)

0.28

 

Intermediate (245)

75.00 (68.00, 87.00)

77.45 (69.40, 88.00)

(-1.00, 4.80)

0.23

 

Final (236)

76.00 (69.00, 88.20)

79.00 (70.00, 88.30)

(-1.00, 5.00)

0.24

 

Change (236)

1.10 (0.50, 2.00)

1.50 (0.50, 2.50)

(-0.20, 0.50)

0.53

MUAC, cm

     
 

Baseline (255)

13.00 (11.20, 14.00)

13.00 (11.90, 14.25)

(-0.70, 0.25)

0.35

 

Intermediate (245)

13.50 (12.00, 14.50)

14.00 (12.50, 15.00)

(-0.10, 0.80)

0.18

 

Final (237)

13.80 (12.55, 15.00)

14.00 (12.70, 15.00)

(-0.30, 0.50)

0.56

 

Change (237)

1.00 (0.20, 1.50)

0.80 (0.20, 1.50)

(-0.35, 0.20)

0.61

Head Circumference, cm

    
 

Baseline (254)

45.50 (43.00, 48.00)

46.00 (43.50, 48.00)

(-1.00, 0.50)

0.58

 

Intermediate (245)

46.00 (43.80, 48.00)

46.45 (44.00, 48.00)

(-0.50, 1.00)

0.59

 

Final (236)

46.00 (44.10, 48.50)

46.50 (44.40, 48.50)

(-0.50, 1.00)

0.58

 

Change (235)

0.50 (0.00, 1.00)

0.50 (0.00, 1.00)

(-0.20, 0.25)

0.86

Triceps skin-fold thickness, cm

    
 

Baseline (255)

6.20 (5.20, 7.90)

6.15 (5.15, 8.00)

(-0.60, 0.40)

0.55

 

Intermediate (245)

7.10 (5.60, 8.20)

7.20 (6.10, 8.95)

(-0.20, 0.90)

0.25

 

Final (237)

7.50 (6.20, 8.60)

7.20 (6.00, 8.90)

(-0.70, 0.40)

0.61

 

Change (237)

1.05 (-0.20, 2.10)

0.70 (-0.30, 1.90)

(-0.70, 0.20)

0.37

  1. a Intermediate is at 4 weeks follow-up; Final at 8 weeks follow-up; Change between the final and the baseline measurement
  2. b IQR: Interquartile Range
  3. c p-value based on Wilcoxon 2-group comparison